COMPASS Pathways PLC Sponsored ADR

CMPS Healthcare Medical Care Facilities

EPS
+95.1%
Free cash flow
−4.18%
Total debt
+63.1%

Quarter to September 2026, against a year earlier

7.86 0.74 −8.60%
Market cap
$1.2B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 1.79%

Capital & Financial Ratios $m

Size
Market Cap 1,190.00
Revenue ttm —
Net income ttm (266.30)
Free cash flow ttm (176.80)
Net debt Q (393.42)
Valuation
P/E 0.00
Forward P/E —
Price / sales 0.00
Forward P/S Powerpack
Price / FCF 0.00
Price / book 7.67 (above 6: high)
Financial health
Current ratio Q 1.50
Debt / equity Q 0.36 (at or below 0.5: strong)
Interest coverage Q (37.50)
Growth
Revenue growth Q —
Operating income growth Q −39.23% (below 0%: shrinking)
EPS, this year +40.83% (at or above 15%: strong)
EPS, next year A +11.93%
Revenue, next year A —
EPS, past 5 yrs —
EPS, next 5 yrs A +31.04% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/B against its own 10 years 89.47%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 221 165 150 444
Receivables — — — —
Inventory — — — —
Other — — — —
261 201 191 488
2023 2024 2025 Q'26
Payables 6 12 15 9
ST’ Debt — 6 18 1
Other — — 204 297
20 34 248 326

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (0.30) (1.88) (0.06) — —
’25 (0.24) (0.41) (1.44) (1.00) (3.08)
’24 (0.55) (0.56) (0.56) (0.63) (2.30)
’23 (0.57) (0.62) (0.67) (0.49) (2.32)
’22 (0.50) (0.50) (0.43) (0.73) (2.16)
’21 (0.35) (0.44) (0.38) (0.61) (1.79)
’20 (0.93) — (1.30) (0.52) (3.55)
Fiscal quarters ending in the months shown.

Revenue $m

Year
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (48) (40) (51) — —
’25 (46) (39) (35) (38) (157)
’24 (21) (34) (22) (42) (119)
’23 (28) (25) (17) (28) (97)
’22 (23) (18) (19) (45) (105)
’21 (14) (18) (14) (22) (68)
’20 (4) (6) (14) (17) (41)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (48) (40) (51) — —
’25 (46) (39) (35) (38) (157)
’24 (21) (34) (22) (42) (119)
’23 (28) (25) (17) (28) (97)
’22 (23) (18) (19) (45) (106)
’21 (14) (18) (14) (22) (68)
’20 (5) (6) (14) (17) (42)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — — — — — — — 40 40 191 +119.3%
Gross margin, % — — — — — — — — — — — —
EBT — — (13) (20) (60) (72) (91) (118) (154) (290) (270) +55.5%
EBT margin, % — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0 pt
Net income — 0 (13) (20) (60) (72) (92) (118) (155) (288) (266) n/m
Per share, $
Per share, $ Revenue — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 n/m
Earnings — — (0.40) (2.62) (3.55) (1.79) (2.16) (2.32) (2.30) (3.08) (2.24) +33.9%
Cash flow — — (0.30) (2.38) (2.44) (1.69) (2.48) (1.91) (1.77) (1.68) (1.27) +28.2%
Capex — — 0.00 (0.02) (0.01) (0.01) (0.01) 0.00 0.00 0.00 0.00 n/m
Free cash flow — — (0.30) (2.40) (2.44) (1.70) (2.50) (1.91) (1.77) (1.68) (1.27) +27.9%
Book value — — (0.43) (4.06) 11.57 7.11 4.27 4.42 2.29 (0.57) 1.02 +3.9%
Shares, m — — 33 7 17 40 42 51 67 94 119 +16.0%
Valuation, ×
Valuation, × P/E — — — — — — — — — — 0 —
P/S — — — — — — — — — — 0 —
P/B — — — — — — — — — — 0 —
EV/Sales — — — — — — — — — — 0 —
EV/FCF — — — — — — — — — — 0 —
Cash, $m
Cash, $m Operating cash flow — — (10) (18) (41) (68) (105) (97) (119) (157) (177) +48.7%
Capex — — 0 0 0 0 (1) 0 — — 0 (13.2%)
Free cash flow — — (10) (18) (42) (68) (106) (97) (119) (157) (177) +48.4%
Balance, $m
Balance, $m Working capital — — 24 8 196 280 176 242 167 (56) 162 n/m
Net debt — — (23) (4) (190) (272) (143) (192) (135) (118) (393) +26.4%
Shareholders’ equity — — (14) (30) 197 284 181 226 155 (53) 142 +20.4%
Returns, %
Returns, % ROA — — (100.20) (66.74) (51.16) (28.45) (36.73) (50.06) (63.36) (135.78) (72.25) (35.6) pt
ROIC — — 0.00 0.00 (517.66) (417.98) (180.08) (252.71) (574.41) 0.00 0.00 0.0 pt
ROE — — 59.07 87.64 (72.62) (29.83) (39.30) (58.21) (81.55) (565.28) (311.56) (624.3) pt
People
People Employees — — — 53 62 116 181 186 166 156 — +19.7%
Revenue/emp, $m — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fundamentals updated 5 Nov 2026

COMPASS Pathways PLC Sponsored ADR vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ARDT Ardent Health, Inc. $1.8B 15.2× 12.8× +3.05% (above 0%: growing) n/m −23.49% (below 0%: shrinking) 100.00% 0.00% Compare
HCSG Healthcare Services Group, Inc. $1.8B 16.6× 18.6× +3.29% (above 0%: growing) −37.29% (below 0%: shrinking) −59.81% (below 0%: shrinking) 16.76% 6.66% Compare
SNDA Sonida Senior Living, Inc. $1.8B — (loss-making) — (loss-making) +114.40% (above 0%: growing) n/m +360.11% (above 0%: growing) 35.68% (9.27%) Compare
AGL Agilon Health, Inc. $1.6B — (loss-making) — (loss-making) +5.86% (above 0%: growing) n/m +234.38% (above 0%: growing) 0.00% 1.59% Compare
PNTG The Pennant Group, Inc. $1.5B 37.3× 36.7× +31.96% (above 0%: growing) +55.56% (above 0%: growing) −3.19% (below 0%: shrinking) 13.34% 5.46% Compare
NUTX Nutex Health Inc. $1.4B 7.4× 7.3× −13.62% (below 0%: shrinking) n/m +19.44% (above 0%: growing) 67.04% 57.75% Compare
INNV InnovAge Holding Corp. $1.3B 124× 20.9× +12.14% (above 0%: growing) +155.00% (above 0%: growing) +18,885.62% (above 0%: growing) 24.02% 7.61% Compare
USPH U.S. Physical Therapy, Inc. $1.3B — (loss-making) 45.8× +12.90% (above 0%: growing) n/m +32.17% (above 0%: growing) 19.34% 0.00% Compare
CMPS COMPASS Pathways PLC Sponsored ADR $1.2B — (loss-making) — — n/m −4.18% (below 0%: shrinking) — 0.00%
Median of peers $1.6B 16.6× 19.8× +9.00% +55.56% +25.81% 21.68% 3.53%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 15 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 2.12m 4.23m 86.00
2024 4.34m 163.40k 22.00
2023 2.82m 2.38m 51.00

Ownership

Directors and executive officers, together 2.82%
RTW Investments, LP 9.99%
Entities affiliated with Deep Track 9.99%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

COMPASS Pathways PLC Sponsored ADR (CMPS) Latest News

21 Sep

Impact 3 · · MarketBeat
stockrow.com/CMPS · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com